Table 1.

Demographic, serological, clinical, and clinometric characteristics of patients with SLE at baseline. Values are n (%) unless otherwise specified.

Patients, n189
  Female175 (92.5)
  Male14 (7.4)
Age at diagnosis, yrs, median (IQR)31 (24–39)
Autoantibody profile
  Anti-dsDNA105 (55.5)
  Anti-Sm30 (15.8)
  aPL43 (22.7)
Severe SLE116 (61.3)
Ever smokers84 (44.4)
Obesity15 (7.9)
Hypertension49 (25.9)
Dyslipidemia23 (12.1)
Diabetes8 (4.2)
SELENA-SLEDAI, mean ± SD7 ± 4.1
SDI, median (range)0 (0–3)
  • SLE: systemic lupus erythematosus; IQR: interquartile range; aPL: antiphospholipid antibodies; SELENA: Safety of Estrogens in Lupus Erythematosus National Assessment; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; SDI: Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index.